Does Pomegranate Endothelial Function Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Pomegranate Endothelial Function Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - 1 2 3 4 5 High blood pressure (BP) is the primary risk factor for developing cardiovascular disease (CVD), which is the leading cause of death worldwide. [Betanzos-Cabrera Gabriel (2026); evidence level 2] - Microencapsulated pomegranate juice (MPJ) improved endothelial dysfunction in women with acute coronary syndrome and in New Zealand rabbits [,]. [Betanzos-Cabrera Gabriel (2026); evidence level 2] - Women were selected for this study to avoid gender bias which could result from a male and female cohort. [Betanzos-Cabrera Gabriel (2026); evidence level 2] - According to a WHO report on the global burden of hypertension, more than 1.6 billion people will have hypertension by 2025 [,]. [Betanzos-Cabrera Gabriel (2026); evidence level 2] - Hormonal changes associated with this stage of life contribute to a higher CVD risk, driven by factors such as visceral obesity, atherogenic dyslipidemia, vascular dysfunction, and high blood pressure (BP). [Almoraie Manal M (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.